{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:11:44Z","timestamp":1792087904390,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":813,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry &amp; Biology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.chembiol.2011.04.011","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T10:51:21Z","timestamp":1309171881000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":333,"title":["In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases"],"prefix":"10.1016","volume":"18","author":[{"given":"Matthew\u00a0P.","family":"Patricelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyzoon\u00a0K.","family":"Nomanbhoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subadhra","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwin","family":"Aban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Okerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Weissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiing-Dwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael\u00a0S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John\u00a0W.","family":"Kozarich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2011.04.011_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib2","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.1158\/0008-5472.CAN-06-0453","article-title":"Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib","volume":"66","author":"Carey","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2011.04.011_bib3","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2011.04.011_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases\u2013the major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2011.04.011_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(95)00357-F","article-title":"SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1","volume":"364","author":"Cuenda","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2011.04.011_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nbt.1661","article-title":"Options and considerations when selecting a quantitative proteomics strategy","volume":"28","author":"Domon","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/bi971332s","article-title":"Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity","volume":"37","author":"Donella-Deana","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2011.04.011_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.0.CO;2-2","article-title":"ATP site-directed competitive and irreversible inhibitors of protein kinases","volume":"20","author":"Garcia-Echeverria","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.chembiol.2011.04.011_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(99)80028-3","article-title":"Organization and regulation of mitogen-activated protein kinase signaling pathways","volume":"11","author":"Garrington","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib10","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-2590","article-title":"Inhibition of the\u00a0T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647","volume":"13","author":"Gendreau","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2011.04.011_bib11","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1073\/pnas.2535024100","article-title":"An efficient proteomics method to identify the cellular targets of protein kinase inhibitors","volume":"100","author":"Godl","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2011.04.011_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-5521(99)80088-X","article-title":"Paradoxical activation of Raf by a novel Raf inhibitor","volume":"6","author":"Hall-Jackson","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/sj.onc.1202603","article-title":"Effect of SB 203580 on the activity of c-Raf in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Hall-Jackson","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2011.04.011_bib14","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1073\/pnas.0702654104","article-title":"The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib","volume":"104","author":"Hantschel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2011.04.011_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2011.04.011_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2011.04.011_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.molcel.2009.10.017","article-title":"C-Raf inhibits MAPK activation and transformation by B-Raf(V600E)","volume":"36","author":"Karreth","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2011.04.011_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.chembiol.2005.04.011","article-title":"Features of selective kinase inhibitors","volume":"12","author":"Knight","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib20","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in\u00a0vitro and in\u00a0vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2011.04.011_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1875397300801010043","article-title":"Fluroescent cascade and direct assays for characterization of RAF signaling pathway inhibitors","volume":"1","author":"Kupcho","year":"2008","journal-title":"Curr. Chem. Genomics"},{"key":"10.1016\/j.chembiol.2011.04.011_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-894X(99)00668-X","article-title":"The discovery of potent cRaf1 kinase inhibitors","volume":"10","author":"Lackey","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2011.04.011_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt826","article-title":"Discovering potent and selective reversible inhibitors of enzymes in complex proteomes","volume":"21","author":"Leung","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Liu","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2011.04.011_bib26","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.0909299107","article-title":"Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta\/B-RAF","volume":"107","author":"Murphy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2011.04.011_bib27","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/cr0002801","article-title":"Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions","volume":"101","author":"Newton","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2011.04.011_bib28","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1095920","article-title":"Protein kinase inhibitors: insights into drug design from structure","volume":"303","author":"Noble","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2011.04.011_bib29","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1073\/pnas.0501205102","article-title":"High-resolution functional proteomics by active-site peptide profiling","volume":"102","author":"Okerberg","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2011.04.011_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nsb770","article-title":"Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site","volume":"9","author":"Pargellis","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bi062142x","article-title":"Functional interrogation of the kinome using nucleotide acyl phosphates","volume":"46","author":"Patricelli","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2011.04.011_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2011.04.011_bib33","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/S0960-894X(03)00656-5","article-title":"The kinetics of binding to p38MAP kinase by analogues of BIRB 796","volume":"13","author":"Regan","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2011.04.011_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1124\/mol.106.027656","article-title":"Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer","volume":"71","author":"Schiffer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cbpa.2009.08.016","article-title":"Directed mass spectrometry: towards hypothesis-driven proteomics","volume":"13","author":"Schmidt","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nmeth.1373","article-title":"Proteomics strategy for quantitative interaction profiling in cell extracts","volume":"6","author":"Sharma","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2011.04.011_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2217\/fon.09.56","article-title":"Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment","volume":"5","author":"Smalley","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.chembiol.2011.04.011_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bmcl.2005.09.072","article-title":"The identification of potent and selective imidazole-based inhibitors of B-Raf kinase","volume":"16","author":"Takle","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2011.04.011_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2174\/092986730609220401150028","article-title":"The structure-based design of ATP-site directed protein kinase inhibitors","volume":"6","author":"Toledo","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.chembiol.2011.04.011_bib40","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2011.04.011_bib41","first-page":"3595","article-title":"Active Ras induces heterodimerization of cRaf and BRaf","volume":"61","author":"Weber","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2011.04.011_bib42","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2011.04.011_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-291X(88)80280-8","article-title":"Phorbol 12-myristate 13-acetate inhibition of leukotriene D4-induced signal transduction was rapidly reversed by staurosporine","volume":"157","author":"Winkler","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Chemistry &amp; Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107455211100161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107455211100161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:16:49Z","timestamp":1761031009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107455211100161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S107455211100161X"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2011.04.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13271973.14627077","asserted-by":"object"}]},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2011.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}